Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.